onmynews.com
Shares Of Biotech Firm Abivax Surge 35% After Fresh Data In Lead Drug Trial
Abivax has been seen as a prime takeover target, with rumours claiming that several Big Pharma companies are keen to acquire the Paris-based biotech firm.